National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
IN THIS ISSUE
An NCI Perspective on Epidemiology

Epidemiology in a Nutshell

Animation/Video

Audio Clips

Photos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
 
    View All Issues  

MEDIA RESOURCES
Noticias En Español

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page
BenchMarks
------
VOLUME 2, ISSUE 7
------
Audio

TRANSCRIPT: Audio clip from an interview about Epidemiology with Robert Hoover, M.D., Sc.D, NCI:
Q: What are the priorities for future epidemiological studies?


Dr. Hoover: Epidemiology is an opportunistic science. It goes where the action is not only in terms of disease and exposure, but also where the tools are. Many epidemiologists are most anxious to use the new molecular tools to assess exposures better, as well as measuring susceptibility. For example, it would be wonderful to have a biological dosimeter for your exposure to benzene from gasoline fumes, or your lifetime level of consumption of fat in your diet. It's difficult to get at these kinds of exposures by asking questions. We are hopeful that the emerging technology from measurement science will provide opportunities in this area. That is an area all of us hope will come to fruition.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov